AHPI:NSD-Allied Healthcare Products Inc (USD)

COMMON STOCK | Medical Devices | NSD

Last Closing Price

USD 7.05

Change

-0.61 (-7.96)%

Market Cap

USD 0.03B

Volume

0.21M

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Allied Healthcare Products, Inc. manufactures and markets respiratory products for use in the health care industry in a range of hospitals and alternate site settings worldwide. The company offers respiratory care/anesthesia products, including air compressors, calibration equipment, humidifiers, croup tents, and equipment dryers, as well as respiratory disposable products, such as oxygen tubing products, facemasks, cannulas, and ventilator circuits; and home respiratory care products comprising aluminum oxygen cylinders, oxygen regulators, pneumatic nebulizers, portable suction equipment, and a line of respiratory disposable products. It also provides medical gas equipment, which include construction products consisting of in-wall medical system components, central station pumps and compressors, and headwalls; regulation devices and suction equipment comprising flowmeters, vacuum regulators, and pressure regulators, as well as related adapters, fittings, and hoses that measure, regulate, monitor, and transfer medical gases from walled piping or equipment to patients; and disposable oxygen cylinders to provide oxygen for short periods. In addition, the company offers emergency medical products that include respiratory/resuscitation products, such as demand resuscitation valves, portable resuscitation systems, bag masks and related products, emergency transport ventilators, precision oxygen regulators, minilators, multilators, and humidifiers; and trauma and patient handling products that include spine immobilization products, pneumatic anti-shock garments, and trauma burn kits. It serves hospitals, hospital equipment dealers, hospital construction contractors, home health care dealers, emergency medical products dealers, and others. Allied Healthcare Products, Inc. was incorporated in 1979 and is headquartered in St. Louis, Missouri. Address: 1720 Sublette Avenue, Saint Louis, MO, United States, 63110

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-09-20 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ALGN Align Technology Inc

-9.74 (-1.35%)

USD55.78B 80.35 56.77
PODD Insulet Corporation

-3.40 (-1.16%)

USD20.14B 2,208.27 247.34
ABMD Abiomed Inc

-7.62 (-2.15%)

USD15.76B 102.71 54.27
LVGO Livongo Health, Inc

N/A

USD14.20B N/A N/A
BRKR Bruker Corporation

-0.65 (-0.78%)

USD12.59B 53.70 28.22
SWAV ShockWave Medical Inc

-13.16 (-5.80%)

USD7.98B N/A N/A
TNDM Tandem Diabetes Care Inc

-0.26 (-0.21%)

USD7.72B 1,188.64 239.94
IART Integra LifeSciences Holdings ..

-0.34 (-0.49%)

USD5.89B 28.84 19.16
INMD InMode Ltd

-1.42 (-1.00%)

USD5.45B 47.70 40.15
LIVN LivaNova PLC

-2.04 (-2.46%)

USD4.41B 77.40 N/A

ETFs Containing AHPI

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 44.76% 67% D+ 86% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.76% 67% D+ 85% B
Trailing 12 Months  
Capital Gain 25.44% 38% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.44% 38% F 46% F
Trailing 5 Years  
Capital Gain 540.91% 94% A 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 540.91% 94% A 93% A
Average Annual (5 Year Horizon)  
Capital Gain 105.02% 89% B+ 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 105.02% 89% B+ 93% A
Risk Return Profile  
Volatility (Standard Deviation) 232.64% 11% F 6% F
Risk Adjusted Return 45.14% 62% D- 62% D-
Market Capitalization 0.03B 4% F 5% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 3.41 66% D 41% F
Price / Cash Flow Ratio 43.69 13% F 10% F
EV/EBITDA 197.27 14% F 5% F
Management Effectiveness  
Return on Equity -4.39% 76% C 49% F
Return on Invested Capital -25.34% 52% F 26% F
Return on Assets 2.49% 85% B 67% D+
Debt to Equity Ratio 15.00% 64% D 65% D
Technical Ratios  
Short Ratio 0.02 100% A+ 99% A+
Short Percent 5.71% 35% F 31% F
Beta -5.51 100% A+ 100% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector